Synthetic Optimization and MAPK Pathway Activation Anticancer Mechanism of Polyisoprenylated Cysteinyl Amide Inhibitors
Abnormalities of the MAPK pathway play vital roles in cancer initiation and progression. RAS GTPases that are key upstream mediators of the pathway are mutated in 30% of human cancers. Polyisoprenylated cysteinyl amide inhibitors (PCAIs) were designed as potential targeted therapies against the RAS-...
Guardado en:
Autores principales: | Nada Tawfeeq, Yonghao Jin, Nazarius S. Lamango |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/05a1a60610a44f6fa90ded99059fe538 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Involvement of the ERK MAPK Cascade in the Formation of Adhesions in the Abdominal Cavity
por: I. A. Shurygina, et al.
Publicado: (2021) -
CCAT2 is an oncogenic long non-coding RNA in pancreatic ductal adenocarcinoma
por: Cai,Yi, et al.
Publicado: (2018) -
Sleeve Gastrectomy Ameliorates Diabetes-Induced Cardiac Hypertrophy Correlates With the MAPK Signaling Pathway
por: Qian Xu, et al.
Publicado: (2021) -
Effect of iron on the activation of the MAPK/ERK pathway in PC12 neuroblastoma cells
por: MUÑOZ,PABLO, et al.
Publicado: (2006) -
Curculigoside Ameliorates Bone Loss by Influencing Mesenchymal Stem Cell Fate in Aging Mice
por: Na Wang, et al.
Publicado: (2021)